Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

冠状动脉血运重建术后心绞痛中西医结合诊疗指南

2020-10-13 世界中医药学会联合会心血管病专业委员 中国中西医结合杂志.2020.10.

心绞痛

为规范和指导临床医师对冠脉介入术后患者的诊断、中医辨证论治，本指南制定工作组根据国内外中西医结合防治冠脉血运重建术后的研究进展，在文献系统评价及证据分级基础上袁汇集专家经验，形成了《冠状动脉血运重建术

中文标题：

冠状动脉血运重建术后心绞痛中西医结合诊疗指南

发布机构：

世界中医药学会联合会心血管病专业委员

发布日期：

2020-10-13

简要介绍：

为规范和指导临床医师对冠脉介入术后患者的诊断、中医辨证论治，本指南制定工作组根据国内外中西医结合防治冠脉血运重建术后的研究进展，在文献系统评价及证据分级基础上袁汇集专家经验，形成了《冠状动脉血运重建术后心绞痛中西医结合诊疗指南》。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=冠状动脉血运重建术后心绞痛中西医结合诊疗指南_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d42bc1c00200ae27, title=冠状动脉血运重建术后心绞痛中西医结合诊疗指南, enTitle=, guiderFrom=中国中西医结合杂志.2020.10., authorId=0, author=, summary=为规范和指导临床医师对冠脉介入术后患者的诊断、中医辨证论治，本指南制定工作组根据国内外中西医结合防治冠脉血运重建术后的研究进展，在文献系统评价及证据分级基础上袁汇集专家经验，形成了《冠状动脉血运重建术, cover=https://img.medsci.cn/20201031/1604154884165_2020535.jpg, journalId=0, articlesId=null, associationId=1868, associationName=世界中医药学会联合会心血管病专业委员, associationIntro= , copyright=0, guiderPublishedTime=Tue Oct 13 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>为规范和指导临床医师对冠脉介入术后患者的诊断、中医辨证论治，本指南制定工作组根据国内外中西医结合防治冠脉血运重建术后的研究进展，在文献系统评价及证据分级基础上袁汇集专家经验，形成了《冠状动脉血运重建术后心绞痛中西医结合诊疗指南》。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1180, tagName=心绞痛)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1180, guiderKeyword=心绞痛, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3893, appHits=183, showAppHits=0, pcHits=837, showPcHits=3710, likes=0, shares=18, comments=20, approvalStatus=1, publishedTime=Sat Oct 31 23:09:01 CST 2020, publishedTimeString=2020-10-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 22:34:59 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:39:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=冠状动脉血运重建术后心绞痛中西医结合诊疗指南_.pdf)])
冠状动脉血运重建术后心绞痛中西医结合诊疗指南_.pdf
下载请点击：
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208450, encodeId=c2c71208450c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:52:41 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057188, encodeId=5f26105e18873, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:11:07 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998726, encodeId=f6c6998e26e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Mon Jul 12 10:38:54 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976897, encodeId=e3599e689732, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/cedc267f75694c8ca659796851773bff/9020d39ab4f84dcdb86ff168345eb91c.jpg, createdBy=e94a5534368, createdName=s。, createdTime=Fri Jun 25 20:46:12 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951215, encodeId=38e7951215f1, content=学习好资料！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Mar 25 16:43:42 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2022-04-03 Alliswell999

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208450, encodeId=c2c71208450c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:52:41 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057188, encodeId=5f26105e18873, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:11:07 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998726, encodeId=f6c6998e26e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Mon Jul 12 10:38:54 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976897, encodeId=e3599e689732, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/cedc267f75694c8ca659796851773bff/9020d39ab4f84dcdb86ff168345eb91c.jpg, createdBy=e94a5534368, createdName=s。, createdTime=Fri Jun 25 20:46:12 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951215, encodeId=38e7951215f1, content=学习好资料！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Mar 25 16:43:42 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-10-03 H8888888

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208450, encodeId=c2c71208450c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:52:41 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057188, encodeId=5f26105e18873, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:11:07 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998726, encodeId=f6c6998e26e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Mon Jul 12 10:38:54 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976897, encodeId=e3599e689732, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/cedc267f75694c8ca659796851773bff/9020d39ab4f84dcdb86ff168345eb91c.jpg, createdBy=e94a5534368, createdName=s。, createdTime=Fri Jun 25 20:46:12 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951215, encodeId=38e7951215f1, content=学习好资料！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Mar 25 16:43:42 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-07-12 乌拉小草

    好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208450, encodeId=c2c71208450c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:52:41 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057188, encodeId=5f26105e18873, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:11:07 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998726, encodeId=f6c6998e26e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Mon Jul 12 10:38:54 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976897, encodeId=e3599e689732, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/cedc267f75694c8ca659796851773bff/9020d39ab4f84dcdb86ff168345eb91c.jpg, createdBy=e94a5534368, createdName=s。, createdTime=Fri Jun 25 20:46:12 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951215, encodeId=38e7951215f1, content=学习好资料！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Mar 25 16:43:42 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-06-25 s。

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1208450, encodeId=c2c71208450c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628096168, createdName=Alliswell999, createdTime=Sun Apr 03 21:52:41 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057188, encodeId=5f26105e18873, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:11:07 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998726, encodeId=f6c6998e26e7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Mon Jul 12 10:38:54 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976897, encodeId=e3599e689732, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210625/cedc267f75694c8ca659796851773bff/9020d39ab4f84dcdb86ff168345eb91c.jpg, createdBy=e94a5534368, createdName=s。, createdTime=Fri Jun 25 20:46:12 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951215, encodeId=38e7951215f1, content=学习好资料！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Mar 25 16:43:42 CST 2021, time=2021-03-25, status=1, ipAttribution=)]
    2021-03-25 14643f34m67暂无昵称

    学习好资料！！

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2017NICE指南：心脏CT是冠状动脉疾病的最佳检验方法

国家卫生和护理研究所（NICE） · 2017-03-27

拓展阅读

2017NICE指南：心脏CT是冠状动脉疾病的最佳检验方法

国家卫生和护理研究所（NICE） · 2017-03-27

心绞痛整体治疗共识声明

暂未更新 · 2021-09-02

Baidu
map
Baidu
map
Baidu
map